Health Condition 1: null- ASA 1and 2 and3
Conditions
Interventions
Intervention1: dexmedetomidine: Loading dose of 1 microgm/kg Dexmedetomidine will be given as intravenous infusion over 10 minutes after echocardiography, pulse oximetry , end tidal carbon-di-oxide, r
Sponsors
AIIMS NEW DELHI
Eligibility
Inclusion criteria
Inclusion criteria: all awake consenting patients undergoing awake craniotomy
Exclusion criteria
Exclusion criteria: are uncooperative, with diminished levels of consciousness, mental retardation, with anticipated difficult intubation, obstructive sleep apnoea, medical conditions preventing to lie down for many hours, severe bradycardia, any type of atrioventricular block on the ECG, heart failure, and allergy to the study drugs will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the respiratory complications (Hypoventilation, Hypoxia, Hypercarbia, Desaturation SpO2 90%, Airway obstruction) between the two groups Timepoint: intraoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| haemodynamic disturbances, pain, nausea/vomiting, brain bulge, seizures, duration of postoperative analgesiaTimepoint: Intraoperatively at: 1.Baseline 2.10 minutes after starting infusion 3.During scalp block 4.During pin fixation 5.During skin incision 6.During bone flap elevation 7. During dural incision 8. Dt tumor excision 9. At dural closure 10.At skin closure Postoperatively when patient will complain pain first time with VAS Score more then 4 after surgery | — |
Countries
India
Contacts
Public ContactGirija Prasad Rath
AIIMS, New Delhi
Outcome results
None listed